Biognosys Licenses ETH Zurich Patent for Glycoprotein Enrichment | GenomeWeb

NEW YORK (GenomeWeb) – Proteomics firm Biognosys said this week that it has licensed a patent from the Swiss Federal Institute of Technology Zurich covering a technology for capture of N-glycans.

The company said that it plans to use the technology to offer glycol-protein profiling as part of its high-resolution mass spec-based targeted quantitation offerings.

Developed by ETH Zurich research Ruedi Aebersold and colleagues at the Institute for Systems Biology in Seattle, the technique enables enrichment of N-glycosylated proteins.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.